Washington -- The U.S. Food and Drug Administration (FDA) granted regulatory approval for a new contraceptive device for female white-tailed deer.
Washington
-- The U.S. Food and Drug Administration (FDA) has granted regulatory approval for a new contraceptive device for female white-tailed deer.
The immunocontraceptive vaccine, GonaCon™, can be used in white-tailed deer older than 1 year. The single-shot, multi-year vaccine stimulates the production of antibodies that bind to the gonadotropin-releasing hormone (GnRH), which signals the production of sex hormones, says FDA. The antibodies therefore reduce GnRH’s ability to stimulate the release of sex hormones, sexual activity is decreased, and animals remain in a non-reproductive state while the antibodies are present.
GonaCon is a restricted-use pesticide, and users must have appropriate certifications. Only USDA-WS or state wildlife management agency personnel and persons working under their authority are permitted to use the vaccine. It is meant to be used in conjunction with other wildlife management methods, says FDA, and was made available beginning in January.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More